[(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol

C16H20N4O — CID 97169661

IUPAC[(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol
SMILESOC[C@H]1CCCN1c1nc2ccccc2nc1NC1CC1
InChIInChI=1S/C16H20N4O/c21-10-12-4-3-9-20(12)16-15(17-11-7-8-11)18-13-5-1-2-6-14(13)19-16/h1-2,5-6,11-12,21H,3-4,7-10H2,(H,17,18)/t12-/m1/s1
InChIKeyOZQQQRYLDRIJPC-GFCCVEGCSA-N
MW284.36 g/mol
LogP2.17
Rot. Bonds4

About [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol

[(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol (PubChem CID 97169661) has the molecular formula C16H20N4O and a molecular weight of 284.36 g/mol. Its IUPAC name is [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol.

Molecular Properties

Compound Name[(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol
PubChem CID97169661
Molecular FormulaC16H20N4O
Molecular Weight284.36 g/mol
Exact Mass284.16
IUPAC Name[(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol
SMILESOC[C@H]1CCCN1c1nc2ccccc2nc1NC1CC1
InChIInChI=1S/C16H20N4O/c21-10-12-4-3-9-20(12)16-15(17-11-7-8-11)18-13-5-1-2-6-14(13)19-16/h1-2,5-6,11-12,21H,3-4,7-10H2,(H,17,18)/t12-/m1/s1
InChIKeyOZQQQRYLDRIJPC-GFCCVEGCSA-N
XLogP2.17
TPSA61.28 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500284.36
LogP ≤ 52.17
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[1-(3-methoxyquinoxalin-2-yl)pyrrolidin-2-yl]methanol
CID 71648493
[(2R)-1-(3-ethoxyquinoxalin-2-yl)piperidin-2-yl]methanol
CID 97177742
[1-[3-(aminomethyl)quinolin-2-yl]pyrrolidin-2-yl]methanol
CID 61410857
N'-hydroxy-2-[2-(hydroxymethyl)pyrrolidin-1-yl]quinoline-3-carboximidamide
CID 77034286
[1-(1,3-benzoxazol-2-yl)pyrrolidin-2-yl]methanol
CID 22220871
3-(4-cyclopentylsulfonylpiperazin-1-yl)-N-cyclopropylquinoxalin-2-amine
CID 90039114
[1-[3-(aminomethyl)quinolin-2-yl]azepan-2-yl]methanol
CID 116634094
methyl 3-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-phenylquinoxaline-6-carboxylate
CID 67042109
3-[3-(aminomethyl)pyrrolidin-1-yl]-N-cyclopropylquinoxalin-2-amine;hydrochloride
CID 71644805
[1-(2-chloroquinolin-4-yl)pyrrolidin-2-yl]methanol
CID 137363110
N-[[1-(3-methylquinoxalin-2-yl)pyrrolidin-2-yl]methyl]propan-2-amine
CID 62591635
1-[4-[[3-[(3aS,6aR)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]quinoxalin-2-yl]amino]cyclohexyl]piperidin-2-one
CID 167802123

Frequently Asked Questions

What is the IUPAC name of [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol?
The IUPAC name of [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol (CID 97169661) is [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol.
What is the SMILES notation for [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol?
The canonical SMILES for [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol is OC[C@H]1CCCN1c1nc2ccccc2nc1NC1CC1.
What is the InChIKey of [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol?
The InChIKey is OZQQQRYLDRIJPC-GFCCVEGCSA-N. The full InChI is InChI=1S/C16H20N4O/c21-10-12-4-3-9-20(12)16-15(17-11-7-8-11)18-13-5-1-2-6-14(13)19-16/h1-2,5-6,11-12,21H,3-4,7-10H2,(H,17,18)/t12-/m1/s1.
What are the key properties of [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol?
[(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol has a molecular weight of 284.36 g/mol, XLogP of 2.17, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R)-1-[3-(cyclopropylamino)quinoxalin-2-yl]pyrrolidin-2-yl]methanol is sourced from PubChem (CID 97169661), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).